Tyme Technologies, Inc. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2015-12-30: Form 8-K; Period of report 2015-12-23; Description 3.02 Unregistered Sales of Equity Securities; Details 3.02.
- 2015-11-16: Form 8-K; Period of report 2015-11-13; Description 4.01 Changes in Registrant's Certifying Accountant; Details 4.01.
- 2015-10-27: Form 8-K; Period of report 2015-10-26; Description 8.01 Other Events; Details 8.01.
- 2015-10-14: Form 8-K; Period of report 2015-10-08; Description 4.01 Changes in Registrant's Certifying Accountant; Details 4.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2015-12-30 | 8-K | 2015-12-23 | 3.02 Unregistered Sales of Equity Securities | 3.02 On December 23, 2015, pursuant to a Securities Purchase Agreement, dated as of December 18, 2015 (the “Securities Purchase Agreement”), for the aggregate consideration of $3,000,000, we sold and issued to a total of three individuals and entities an aggregate of: (x) 750,000 shares (each, a “Share”) of the common stock, par value $0.0001 per share (the “Common Stock”), of the Company and (y) 446,500 common stock purchase warrants (each, a “Warrant”). | form_8-k.htm |
| 2015-11-16 | 8-K | 2015-11-13 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On November 13, 2015, we engaged Grant Thornton LLP as our new independent registered public accounting firm to audit our financial statements, commencing with our fiscal year ending December 31, 2015. | form_8-k.htm |
| 2015-10-27 | 8-K | 2015-10-26 | 8.01 Other Events | 8.01 On October 26, 2015, we issued a press release reporting on the acceptance by the U.S. Food and Drug Administration of an Investigational New Drug (IND) application for our SM-88 drug candidate. | form_8-k.htm |
| 2015-10-14 | 8-K | 2015-10-08 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On October 8, 2015, we notified our independent registered public accounting firm, WithumSmith+Brown, PC (“WithumSmith”), that we had determined to change auditors and were, therefore, dismissing WithumSmith, effective immediately. | form_8-k.htm |
| 2015-09-30 | 8-K | 2015-09-30 | 8.01 Other Events | 8.01 On September 30, 2015, we issued a press release reporting on our filing an Investigational New Drug (IND) application with the U.S. Food and Drug Administration for our SM-88 drug candidate. | form_8-k.htm |
| 2015-07-29 | 8-K | 2015-07-23 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | form_8-k.htm |
| 2015-06-10 | 8-K | 2015-06-05 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | form_8-k.htm |
| 2015-05-20 | 8-K | 2015-05-15 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 We have appointed Robert Dickey IV as our Vice President - Finance and Chief Financial Officer. | form_8-k.htm |
| 2015-04-16 | 8-K/A | 2015-03-05 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities; 4.01 Changes in Registrant's Certifying Accountant; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 5.06 Change in Shell Company Status | 1.01 The information contained in Item 2.01 below relating to the various agreements described therein is incorporated into this Item 1.01 by reference. 2.01 On March 5, 2015, our Company, Acquisition Sub, Tyme and certain other parties entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”). 3.02 The information regarding the Bridge Notes and the PPO set forth in Item 2.01, “Completion of Acquisition or Disposition of Assets - The Merger and Related Transactions - The Bridge Financing” and ” - The PPO” are incorporated herein by reference. 4.01 On March 6, 2015, DKM Certified Public Accountants (“DKM”) was dismissed as our independent registered public accounting firm. 5.01 The information regarding change of control of the Company in connection with the Merger set forth in Item 2.01, “Completion of Acquisition or Disposition of Assets—The Merger and Related Transactions” is incorporated herein by reference. 5.02 The information regarding departure and election of directors and departure and appointment of principal officers of the Company in connection with the Merger set forth in Item 2.01, “Completion of Acquisition or Disposition of Assets - The Merger and Related Transactions” is incorporated herein by reference. 5.03 On March 5, 2015, we changed our fiscal year from a fiscal year ending on November 30th of each year, which was used in our most recent filing with the SEC, to one ending on December 31st of each year, which is the fiscal year end of Tyme. 5.06 Prior to the Merger, we were a “shell company” (as such term is defined in Rule 12b-2 promulgated under the Exchange Act). | form_8-k.htm |
| 2015-04-06 | 8-K | 2015-04-01 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Akber Pabani, our Chief Financial Officer, has tendered his resignation, effective April 1, 2015. | form_8-k.htm |
| 2015-03-11 | 8-K | 2015-03-05 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities; 4.01 Changes in Registrant's Certifying Accountant; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 5.06 Change in Shell Company Status | 1.01 The information contained in Item 2.01 below relating to the various agreements described therein is incorporated into this Item 1.01 by reference. 2.01 On March 5, 2015, our Company, Acquisition Sub, Tyme and certain other parties entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”). 3.02 The information regarding the Bridge Notes and the PPO set forth in Item 2.01, “Completion of Acquisition or Disposition of Assets - The Merger and Related Transactions - The Bridge Financing” and ” - The PPO” are incorporated herein by reference. 4.01 On March 6, 2015, DKM Certified Public Accountants (“DKM”) was dismissed as our independent registered public accounting firm. 5.01 The information regarding change of control of the Company in connection with the Merger set forth in Item 2.01, “Completion of Acquisition or Disposition of Assets—The Merger and Related Transactions” is incorporated herein by reference. 5.02 The information regarding departure and election of directors and departure and appointment of principal officers of the Company in connection with the Merger set forth in Item 2.01, “Completion of Acquisition or Disposition of Assets - The Merger and Related Transactions” is incorporated herein by reference. 5.03 On March 5, 2015, we changed our fiscal year from a fiscal year ending on November 30th of each year, which was used in our most recent filing with the SEC, to one ending on December 31st of each year, which is the fiscal year end of Tyme. 5.06 Prior to the Merger, we were a “shell company” (as such term is defined in Rule 12b-2 promulgated under the Exchange Act). | form_8-k.htm |